Pharma sours on the U.K., plus biotech M&A’s quiet roll

Are pharmaceutical companies pulling their money out of the United Kingdom because of Trump? How is biotech M&A pacing this year? And what will vaccine advisors discuss at their closely watched meeting this week?

We discuss all that and more on this week’s episode of “The Readout LOUD.”